Oncobit AG

Oncobit AG is a Swiss-based medtech startup founded in 2018. The company's mission, encapsulated in its slogan "Enabling personalized cancer care," revolves around providing personalized cancer care by matching patients with the most suitable treatment options. Oncobit is at the forefront of developing cancer-specific genomic fingerprinting and personalized monitoring tests which, in tandem with their therapy decision support services, aim to revolutionize cancer treatment strategies. The startup operates within the Biotechnology and Health Care industries and recently received a Fr.150.00K Seed Round investment on 21 January 2022 from Venture Kick. With its pioneering approach and the growing demand for personalized medicine, Oncobit is poised to make a significant impact in the field of cancer treatment.